Where does Molecular Health GmbH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Molecular Health GmbH ranks #48,835 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Molecular Health GmbH hold?

Molecular Health GmbH holds 5 US utility patents granted between 2015 and 2020, spanning 2 technology areas.

What is Molecular Health GmbH's Innovation Score?

Molecular Health GmbH has an Innovation Score of 21.1 out of 100 (8th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Molecular Health GmbH's patent grant rate increasing or decreasing?

Molecular Health GmbH's recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Molecular Health GmbH's patents?

Molecular Health GmbH's patents average 16.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Molecular Health GmbH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Molecular Health GmbH

Q: What technology areas does Molecular Health GmbH focus on?

Molecular Health GmbH's top technology area is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology) with 5 patents, ranking #141 of 676 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Molecular ranks #48,835 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.

#48,835
of 49,997 US assignees by volume: 8th percentile
by Innovation Score (21.1/100): 16.6
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R48835 · Foreign Corporation #48,835 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #48,835/49,997
PHOTO-FINISH Modulus Media Systems
CPC-NARROW G16B · 2 areas
INNOV-THIN 21.1/100
CLAIMS-RICH 16.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Modulus Media Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Molecular’s 21.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (29%) Velocity 0.0 pts (0%) Breadth 5.0 pts (24%) Claim depth 10.0 pts (47%)

Qualcomm Incorporated · highest

85
Molecular Health · this assignee

21
3D Lighting… · lowest

7

What this shows Molecular's Innovation Score is 21.1/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Molecular?

Each dot is one of Molecular’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Molecular’s own 16.6 claims/patent is ABOVE the 10.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Molecular vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Molecular's grants concentrate

Molecular Health GmbH is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology). Peak complete grant year is 2017 (2 grants) versus a trough of 1 in 2015. By volume, Molecular sits between Modulus Media Systems, Inc. and Monnaie Royale Canadienne/Royal Canadian Mint.

Modulus Media Sys…

5
Mokpo National Ma…

5
Molecular Dynamics

5
Molecular Glasses

5
Molecure

5
Moncler S P A

5
Moneyhun Equipmen…

5
Monnaie Royale Ca…

5
Molecular Health ◀

5

What this shows Molecular holds 5 patents at rank #48,898, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Molecular

By rank, the assignees closest to #48,898 in granted patent volume.

Leaders in G16B (Bioinformatics)

Other assignees with the most granted patents in Molecular's primary technology class.

Molecular's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

21 8th percentile higher than 8% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Molecular Health GmbH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	20.0%
2016	1	20.0%
2017	2	40.0%
2020	1	20.0%

Which technologies does Molecular Health GmbH patent most?

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 5

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Molecular Health GmbH's patent record in context - here's where to go next.

Molecular Health GmbH's lead technology class is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology), 100% of its portfolio - see every assignee active in that class. Explore G16B
Ranked #48,835 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Molecular Health GmbH against Modulus Media Systems, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 21.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.